Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

<b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Former Cubist Exec" ALT"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will…

Continue Reading<b>Kaleido Biosciences</b> Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist Exec

Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks4.jpg" NAME"Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics" ALT"Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics"September 18, 2017By…

Continue ReadingBay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics

Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials" ALT"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials"September 18, 2017By Alex Keown,…

Continue ReadingNabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials

Harvard Biotech Guru, VCs Launch With $55 Million Series A

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A" ALT"Harvard Biotech Guru, VCs Launch LifeMine Therapeutics With $55 Million Series A"September 18, 2017By Mark Terry,…

Continue ReadingHarvard Biotech Guru, VCs Launch With $55 Million Series A